Anzeige
Mehr »
Montag, 02.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 805985 | ISIN: FI0009010912 | Ticker-Symbol: R0V
Tradegate
27.02.26 | 15:14
18,540 Euro
+0,22 % +0,040
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
REVENIO GROUP OYJ Chart 1 Jahr
5-Tage-Chart
REVENIO GROUP OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
18,18018,32013:58
18,18018,32013:52

Aktuelle News zur REVENIO GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
REVENIO GROUP Aktie jetzt für 0€ handeln
12.02.Revenio Group Corporation: iCare partners with Mediwhale on AI-powered cardiovascular disease prevention120Revenio Group Corporation | Press Release | February 12, 2026 at 10:15:00 EET iCare, part of Revenio Group, announced today that iCare, a global leader in advanced ophthalmic screening solutions, and...
► Artikel lesen
11.02.Revenio Group Corporation: Financial Statements Release January 1 - December 31, 2025234Revenio Group Corporation | Stock Exchange Release | February 11, 2026 at 09:00:00 EET Continued sales growth and exceptionally strong cash flowThis release is a summary of Revenio's Financial Statements...
► Artikel lesen
15.01.Revenio Group Corporation: Change in the Revenio Leadership Team: Kate Taylor to step down119Revenio Group Corporation | Stock Exchange Release | January 15, 2026 at 14:30:00 EET Leadership team member Dr. Kate Taylor (Vice President, Strategy and Business Development), will step down from...
► Artikel lesen
18.12.25Revenio Group Corporation: Change in the Leadership Team: Robin Pulkkinen to leave his position152Revenio Group Corporation | Stock Exchange Release | December 18, 2025 at 08:30:00 EET Revenio Group Corporation's Chief Financial Officer and member of the Leadership Team, Robin Pulkkinen, has resigned...
► Artikel lesen
30.10.25Revenio Group Q3 2025 slides: Revenue grows 8.1% amid regional variations1
30.10.25Revenio Group Q3 2025: Umsatz übertrifft Prognosen bei moderatem Wachstum1
30.10.25Revenio Group Corporation: Interim report January 1- September 30, 2025344Revenio Group Corporation | Stock Exchange Release | October 30, 2025 at 09:00:00 EET Another quarter of profitable growthThis release is a summary of Revenio's Interim report for January 1- September...
► Artikel lesen
17.09.25Revenio Group Corporation: Revenio is planning to develop its organization to become increasingly customer-centric and is initiating organizational change negotiations216Revenio Group Corporation | Press Release | September 17, 2025 at 11:20:00 EEST In recent years, Revenio Group has made a significant journey from being a diagnostic device provider to becoming a global...
► Artikel lesen
07.08.25Revenio Group Corporation: Half-year report January 1-June 30, 2025225Revenio Group Corporation | Stock Exchange Release | August 07, 2025 at 09:00:00 EEST Net sales and profit development at a good level in a challenging business environmentThis release is a summary...
► Artikel lesen
29.04.25Revenio Group Corporation: Interim report January 1- March 31, 2025296Revenio Group Corporation | Stock Exchange Release | April 29, 2025 at 09:00:00 EEST Strong start to 2025This release is a summary of Revenio's Interim report for January 1- March 31, 2025. The complete...
► Artikel lesen
11.04.25Dividendenbekanntmachungen (11.04.2025)15.832 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADVANCE AUTO PARTS INC  US00751Y1064  0,25 USD  0,2232 EUR  AMERICAN EAGLE OUTFITTERS INC  US02553E1064  0,125 USD  0,1116 EUR  AMERICAN...
► Artikel lesen
28.03.25Revenio Group Corporation: U.S. FDA cleared the new iCare MAIA microperimeter470Revenio Group Corporation | Press Release | March 28, 2025 at 09:00:00 EET Icare, a subsidiary of Revenio Group, has today announced that the U.S. Food and Drug Administration (FDA) has cleared the...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1